BEDMINSTER, N.J., March 4 /PRNewswire-FirstCall/ -- Bioject Medical
Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free drug
delivery systems, announced today that it will be presenting at Invest
Northwest(TM), a life sciences and CEO investor conference on Monday,
March 10, 2003 at 3:20 p.m. PST at the Bell Harbor Conference Center in
Seattle, WA.
The presentation will be webcast and accessible through the Investor
Relations section of Bioject's corporate website at http://www.Bioject.com.
Invest Northwest is a two-day forum for venture capitalists, angel
investors, analysts, investment bankers, institutional investors, pension fund
managers, and pharmaceutical and biotech corporate partners. The event will
provide members of the investment community with an opportunity to meet CEOs
and senior executives from public and private life sciences companies based in
Washington, Oregon, Montana, British Columbia and Alberta.
Invest Northwest is hosted by the Washington Biotechnology & Biomedical
Association (WBBA), in collaboration with BC Biotech, BioAlberta and the
Oregon Biosciences Association. For more information about the event, go to
http://www.investnorthwest.org.
About Bioject
Bioject Medical Technologies Inc., based in Bedminster, New Jersey, with
operations in Portland, Oregon, is an innovative developer and manufacturer of
needle-free drug delivery systems. Needle-free injection works by forcing
medication at high speed through a tiny orifice held against the skin. This
creates a fine stream of high-pressure fluid penetrating the skin and
depositing medication in the tissue beneath.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause the actual results, performance or achievements of the Company,
or industry results, to be materially different from any future results,
performance, or achievements expressed or implied by such forward-looking
statements. Readers of this press release are referred to the Company's
filings with the Securities and Exchange Commission, including the Company's
reports on Forms 10-K and Forms 10-Q for further discussions of factors that
could affect future results. Forward-looking statements are based on the
estimates and opinions of management on the date the statements are made. The
Company assumes no obligation to update forward-looking statements if
conditions or management's estimates or opinions should change.
For more information, please visit Bioject's website at http://www.Bioject.com.
SOURCE Bioject Medical Technologies Inc.
 back to top
Related links:
http://www.bioject.com
CONTACT:
Cecelia C. Heer, Investor Relations Manager
of Bioject Medical Technologies Inc., +1-908-470-2800, ext. 5103,
cheer@bioject.com
|
